With new data on therapies emerging almost every week, artificial intelligence could play a key role in the search for COVID-19 treatment options. Prof Dean Ho, Joint Professor at Department of Pharmacology (NUS Medicine), shared his team’s work in optimising the most effective combination of drugs and doses, while A/Prof David Allen, Associate Vice President (Health Innovation and Translation) at NUS, added that it is critical to be flexible in studying treatment options, as everyone interacts with the virus diffenrently.